Olfactory ensheathing cells but not fibroblasts reduce the duration of autonomic dysreflexia in spinal cord injured rats a b s t r a c t Autonomic dysreflexia	1
Olfactory ensheathing	1
cells but not fibroblasts	23
the duration of autonomic dysreflexia in spinal cord injured rats a b s t r a c t Autonomic dysreflexia	56
the duration	56
autonomic dysreflexia in spinal cord injured rats a b s t r a c t Autonomic dysreflexia	72
autonomic dysreflexia	72
spinal cord injured rats a b s t r a c t Autonomic dysreflexia	97
spinal cord	97
rats a b s t r a c t Autonomic dysreflexia	117
rats	117
a b	124
t r a c t Autonomic dysreflexia	130
t r	130
a c t Autonomic dysreflexia	134
a common complication after high level spinal cord injury	165
a common complication	165
high level spinal cord injury	193
Wehave	252
the acute transplantation of olfactory ensheathing cells into the lesion site of rats transected at the fourth thoracic spinal cord level	281
the acute transplantation	281
olfactory ensheathing cells into the lesion site of rats transected at the fourth thoracic spinal cord level	310
olfactory ensheathing cells	310
the lesion site of rats transected at the fourth thoracic spinal cord level	343
the lesion site	343
rats transected at the fourth thoracic spinal cord level	362
rats	362
the fourth thoracic spinal cord level	381
autonomic dysreflexia	427
up to 8 weeks	449
spinal cord injury	469
This beneficial effect	489
changes in the morphology of sympathetic preganglionic neurons	532
changes	532
the morphology of sympathetic preganglionic neurons	543
the morphology	543
sympathetic preganglionic neurons	561
the olfactory cells	603
than 3 weeks	643
the transitory presence of olfactory ensheathing cells at the injury site	662
the transitory presence	662
olfactory ensheathing cells at the injury site	689
olfactory ensheathing cells	689
the injury site	720
long-termfunctional aswell asmorphological changes	746
the sympathetic preganglionic neurons	800
The primary aim of the present study	839
The primary aim	839
the present study	858
olfactory ensheathing cells	900
transplantation within the parenchyma close	942
transplantation	942
the parenchyma close	965
sympathetic preganglionic neurons	989
this position	1039
they	1054
the duration of autonomic dysreflexia	1072
the duration	1072
autonomic dysreflexia	1088
sympathetic preganglionic neuronmorphology	1123
The second aim	1167
the density of synapses on the somata of sympathetic preganglionic neurons	1198
the density	1198
synapses on the somata of sympathetic preganglionic neurons	1213
synapses	1213
the somata of sympathetic preganglionic neurons	1225
the somata	1225
sympathetic preganglionic neurons	1239
the hypothesis	1278
the reduction of autonomic dysreflexia	1298
the reduction	1298
autonomic dysreflexia	1315
synaptic changes	1346
a third aim	1367
we	1380
the cell type-specificity of olfactory ensheathing cells	1393
the cell type-specificity	1393
olfactory ensheathing cells	1422
their effects	1463
a control group transplanted with fibroblasts	1482
a control group	1482
fibroblasts	1516
Animals transplanted with OECs	1529
Animals	1529
OECs	1555
a faster recovery	1564
hypertension induced by colorectal distension at 6 and 7 weeks but not at 8 weeks after T4 spinal cord transection	1587
hypertension	1587
colorectal distension	1611
6 and 7 weeks	1636
8 weeks	1661
T4 spinal cord transection	1675
Olfactory ensheathing cells	1703
at least 8 weeks	1744
sympathetic preganglionic neurons whose overall number of primary dendrites was reduced	1791
sympathetic preganglionic neurons	1791
whose overall number	1825
primary dendrites	1849
the synaptic density on the somata	1883
the synaptic density	1883
the somata	1907
both caudal to the lesion site.Our	1929
the lesion	1944
a long termcell	1979
type-specific effects of olfactory ensheathing cells	1995
type-specific effects	1995
olfactory ensheathing cells	2020
sympathetic preganglionic neurons morphology	2051
the synaptic density	2103
their somata	2127
a transient cell	2145
type-specific reduction of autonomic dysreflexia	2162
type-specific reduction	2162
autonomic dysreflexia	2189
Introduction Cardiovascular disorders after spinal cord injury	2215
Introduction Cardiovascular disorders	2215
spinal cord injury	2259
a leading cause of morbidity and mortality in spinal cord injured individuals -LRB- Garshick et al. , 2005 ; Myers et al. , 2007 ; Soden et al. , 2000 -RRB-	2288
a leading cause	2288
morbidity and mortality	2307
spinal cord injured individuals -LRB- Garshick et al. , 2005 ; Myers et al. , 2007 ; Soden et al. , 2000 -RRB-	2334
spinal cord	2334
individuals -LRB- Garshick et al. , 2005 ; Myers et al. , 2007 ; Soden et al. , 2000 -RRB-	2354
individuals	2354
Garshick et al. , 2005 ; Myers et al. , 2007 ; Soden et al. , 2000	2367
Garshick	2367
et al. , 2005 ; Myers et al. , 2007 ; Soden et al. , 2000	2376
et al. , 2005	2376
et al.	2376
2005	2384
Myers et al. , 2007	2390
Myers	2390
et al. , 2007	2396
et al.	2396
2007	2404
Soden et al. , 2000	2410
Soden	2410
et al. , 2000	2416
et al.	2416
2000	2424
particular clinical relevance	2434
autonomic dysreflexia which is characterized by a sudden and massive generalized discharge of sympathetic preganglionic neurons below the injury site leading to extremely high arterial blood pressure	2467
autonomic dysreflexia which is characterized by a sudden	2467
autonomic dysreflexia	2467
a sudden	2515
massive generalized discharge of sympathetic preganglionic neurons below the injury site leading to extremely high arterial blood pressure	2528
massive	2528
discharge of sympathetic preganglionic neurons	2548
discharge	2548
sympathetic preganglionic neurons	2561
the injury site leading to extremely high arterial blood pressure	2601
the injury site	2601
extremely high arterial blood pressure	2628
Untreated episodes of autonomic dysreflexia	2668
Untreated episodes	2668
autonomic dysreflexia	2690
serious consequences including epileptic seizures , retinal detachment , stroke and even death , reviewed in -LRB- Wan et al. , 2014 -RRB-	2721
serious consequences	2721
epileptic seizures , retinal detachment , stroke and even death , reviewed in	2752
epileptic seizures	2752
retinal detachment	2772
stroke	2792
even death , reviewed in	2803
even death	2803
Wan	2828
et al. , 2014	2832
et al.	2832
2014	2840
Olfactory ensheathing cells -LRB- OECs -RRB-	2847
Olfactory ensheathing cells	2847
OECs	2876
one of themost promising candidates	2892
one	2892
themost promising candidates	2899
cell-mediated repair following spinal cord injury	2932
cell-mediated repair	2932
spinal cord injury	2963
variability in replication	2991
variability	2991
replication	3006
numerous studies	3019
OECs	3052
awide range of beneficial effects	3069
awide range	3069
beneficial effects	3084
neural repair , tissue sparing , neuroprotection , decreasing cavity formation , modification of the glial scar , angiogenesis and remyelination of demyelinated axons -LRB- Franssen et al. , 2007 ; Mackay-Sim et al. , 2011 ; Raisman et al. , 2012 ; Raisman et al. , 2007 ; Richter et al. , 2008 ; Roet et al. , 2014 ; Yang et al. , 2015 -RRB-	3113
neural repair	3113
tissue sparing , neuroprotection , decreasing cavity formation , modification of the glial scar , angiogenesis and remyelination of demyelinated axons -LRB- Franssen et al. , 2007 ; Mackay-Sim et al. , 2011 ; Raisman et al. , 2012 ; Raisman et al. , 2007 ; Richter et al. , 2008 ; Roet et al. , 2014 ; Yang et al. , 2015 -RRB-	3128
tissue sparing , neuroprotection ,	3128
tissue sparing	3128
neuroprotection	3144
cavity formation	3172
modification of the glial scar , angiogenesis and remyelination of demyelinated axons -LRB- Franssen et al. , 2007 ; Mackay-Sim et al. , 2011 ; Raisman et al. , 2012 ; Raisman et al. , 2007 ; Richter et al. , 2008 ; Roet et al. , 2014 ; Yang et al. , 2015 -RRB-	3189
modification of the glial scar , angiogenesis and remyelination of demyelinated axons	3189
modification	3189
the glial scar , angiogenesis and remyelination of demyelinated axons	3205
the glial scar , angiogenesis and remyelination	3205
axons	3268
Franssen et al. , 2007 ; Mackay-Sim et al. , 2011 ; Raisman et al. , 2012 ; Raisman et al. , 2007 ; Richter et al. , 2008 ; Roet et al. , 2014 ; Yang et al. , 2015	3275
Franssen	3275
et al. , 2007 ; Mackay-Sim et al. , 2011 ; Raisman et al. , 2012 ; Raisman et al. , 2007 ; Richter et al. , 2008 ; Roet et al. , 2014 ; Yang et al. , 2015	3284
et al. , 2007	3284
et al.	3284
2007	3292
Mackay-Sim et al. , 2011	3298
Mackay-Sim	3298
et al. , 2011	3309
et al.	3309
2011	3317
Raisman et al. , 2012	3323
Raisman	3323
et al. , 2012	3331
et al.	3331
2012	3339
Raisman et al. , 2007	3345
Raisman	3345
et al. , 2007	3353
et al.	3353
2007	3361
Richter et al. , 2008	3367
Richter	3367
et al. , 2008	3375
et al.	3375
2008	3383
Roet et al. , 2014	3389
Roet	3389
et al. , 2014	3394
et al.	3394
2014	3402
Yang et al. , 2015	3408
Yang	3408
et al. , 2015	3413
et al.	3413
2015	3421
OEC transplantation	3428
a rat model of autonomic dysreflexia resulting from spinal cord transection at the fourth thoracic spinal cord level -LRB- T4 -RRB- -LRB- Kalincik et al. , 2010a -RRB-	3471
a rat model	3471
autonomic dysreflexia resulting from spinal cord transection at the fourth thoracic spinal cord level -LRB- T4 -RRB- -LRB- Kalincik et al. , 2010a -RRB-	3486
autonomic dysreflexia	3486
spinal cord transection at the fourth thoracic spinal cord level -LRB- T4 -RRB- -LRB- Kalincik et al. , 2010a -RRB-	3523
spinal cord transection	3523
the fourth thoracic spinal cord level -LRB- T4 -RRB- -LRB- Kalincik et al. , 2010a -RRB-	3550
the fourth thoracic spinal cord level -LRB- T4 -RRB-	3550
the fourth thoracic spinal cord level	3550
T4	3589
Kalincik	3594
et al. , 2010a	3603
et al.	3603
2010a	3611
Acute transplantation of OECs at the lesion site	3619
Acute transplantation	3619
OECs at the lesion site	3644
OECs	3644
the lesion site	3652
the duration of autonomic dysreflexia	3676
the duration	3676
autonomic dysreflexia	3692
the morphology of spinal cord	3726
the morphology	3726
spinal cord	3744
sympathetic preganglionic neurons that play a crucial role in central cardiovascular control -LRB- Cabot , 1996 ; Calaresu et al. , 1988 ; Chalmers et al. , 1991 ; Reis et al. , 1988 -RRB-	3756
sympathetic preganglionic neurons	3756
a crucial role in central cardiovascular control -LRB- Cabot , 1996 ; Calaresu et al. , 1988 ; Chalmers et al. , 1991 ; Reis et al. , 1988 -RRB-	3800
a crucial role	3800
central cardiovascular control -LRB- Cabot , 1996 ; Calaresu et al. , 1988 ; Chalmers et al. , 1991 ; Reis et al. , 1988 -RRB-	3818
central cardiovascular control	3818
Cabot , 1996 ; Calaresu et al. , 1988 ; Chalmers et al. , 1991 ; Reis et al. , 1988	3850
Cabot	3850
1996 ; Calaresu et al. , 1988 ; Chalmers et al. , 1991 ; Reis et al.	3857
1996	3857
Calaresu et al. , 1988 ; Chalmers et al. , 1991 ; Reis et al.	3863
Calaresu	3863
et al. , 1988 ; Chalmers et al. , 1991 ; Reis et al.	3872
et al. , 1988	3872
et al.	3872
1988	3880
Chalmers et al. , 1991	3886
Chalmers	3886
et al. , 1991	3895
et al.	3895
1991	3903
Reis et al.	3909
Reis	3909
et al.	3914
1988	3922
These sympathetic preganglionic neurons	3929
autonomic dysreflexia in the T4-transected rat model -LRB- Leman et al. , 2002 -RRB-	4000
autonomic dysreflexia	4000
the T4-transected rat model -LRB- Leman et al. , 2002 -RRB-	4025
the T4-transected rat model	4025
Leman	4054
et al. , 2002	4060
et al.	4060
2002	4068
T4 spinal cord transection	4081
there	4108
a sustained increase in soma size of sympathetic preganglionic neurons with a temporary increase in the number and lengths of their primary dendrites -LRB- Kalincik et al. , 2010b -RRB-	4118
a sustained increase	4118
soma size of sympathetic preganglionic neurons with a temporary increase in the number and lengths of their primary dendrites -LRB- Kalincik et al. , 2010b -RRB-	4142
soma size	4142
sympathetic preganglionic neurons with a temporary increase in the number and lengths of their primary dendrites -LRB- Kalincik et al. , 2010b -RRB-	4155
sympathetic preganglionic neurons	4155
a temporary increase in the number and lengths of their primary dendrites -LRB- Kalincik et al. , 2010b -RRB-	4194
a temporary increase in the number	4194
a temporary increase	4194
the number	4218
lengths of their primary dendrites -LRB- Kalincik et al. , 2010b -RRB-	4233
lengths	4233
their primary dendrites -LRB- Kalincik et al. , 2010b -RRB-	4244
their primary dendrites	4244
Kalincik	4269
et al. , 2010b	4278
et al.	4278
2010b	4286
OEC transplantation into the lesion site	4294
OEC transplantation	4294
the lesion site	4319
the changes	4346
soma size of the sympathetic preganglionic neurons belowthe lesion , while increasing the lengths of dendrites in the sympathetic preganglionic neurons above the lesion -LRB- Kalincik et al. , 2010a ; Kalincik et al. , 2010b -RRB-	4361
soma size	4361
the sympathetic preganglionic neurons belowthe lesion , while increasing the lengths of dendrites in the sympathetic preganglionic neurons above the lesion -LRB- Kalincik et al. , 2010a ; Kalincik et al. , 2010b -RRB-	4374
the sympathetic preganglionic neurons belowthe lesion	4374
the lengths of dendrites in the sympathetic preganglionic neurons	4446
the lengths	4446
dendrites in the sympathetic preganglionic neurons	4461
dendrites	4461
the sympathetic preganglionic neurons	4474
the lesion -LRB- Kalincik et al. , 2010a ; Kalincik et al. , 2010b -RRB-	4518
the lesion	4518
Kalincik	4530
et al. , 2010a ; Kalincik et al. , 2010b	4539
et al.	4539
2010a ; Kalincik et al.	4547
2010a	4547
Kalincik et al.	4554
Kalincik	4554
et al.	4563
2010b	4571
These increases in soma sizes	4579
These increases	4579
soma sizes	4598
9 weeks	4623
OEC transplantation	4637
the increases in dendrite number and length	4661
the increases	4661
dendrite number and length	4678
Kalincik et al. , 2010b	4726
Kalincik	4726
et al.	4735
2010b	4743
these experiments the OECswere transplanted into the lesion site immediately after the spinal cord transection	4755
these experiments	4755
the OECswere	4773
the lesion site	4804
the spinal cord transection	4838
The OECs	4867
no N3 weeks	4885
the transitory presence of OECs at the injury site	4913
the transitory presence	4913
OECs at the injury site	4940
OECs	4940
the injury site	4948
long-term functional as well as morphological changes	4974
This outcome	5029
the transplanted OECs	5069
example by transplanting them into the spinal cord adjacent to the lesion site and not into its epicenter -LRB- Pearse et al. , 2007 -RRB-	5116
example	5116
them	5141
the spinal cord adjacent to the lesion site and not into its epicenter -LRB- Pearse et al. , 2007 -RRB-	5151
the spinal cord	5151
the lesion site	5179
its epicenter -LRB- Pearse et al. , 2007 -RRB-	5208
its epicenter	5208
Pearse	5223
et al. , 2007	5230
et al.	5230
2007	5238
The first aim of the present studywas to evaluatewhether OECs survive after transplantation within the parenchyma close to sympathetic preganglionic neurons and whether , in this position , they still reduce the duration of autonomic dysreflexia and modulate sympathetic preganglionic neuron morphology .	5245
The first aim	5245
the present studywas to evaluatewhether OECs survive after transplantation within the parenchyma close to sympathetic preganglionic neurons and whether , in this position , they still reduce the duration of autonomic dysreflexia and modulate sympathetic preganglionic neuron morphology .	5262
OECs	5302
transplantation within the parenchyma close	5321
transplantation	5321
the parenchyma close	5344
sympathetic preganglionic neurons	5368
this position	5418
they	5433
the duration of autonomic dysreflexia	5451
the duration	5451
autonomic dysreflexia	5467
sympathetic preganglionic neuron morphology	5502
The severity of attacks of autonomic dysreflexia after T4/5 spinal cord transection	5547
The severity	5547
attacks of autonomic dysreflexia after T4/5 spinal cord transection	5563
attacks	5563
autonomic dysreflexia after T4/5 spinal cord transection	5574
autonomic dysreflexia	5574
T4/5 spinal cord transection	5602
a reorganization of synaptic circuitry controlling the activity of sympathetic preganglionic neurons -LRB- Llewellyn-Smith , 2009 ; Maiorov et al. , 1997a ; Maiorov et al. , 1997b ; Marsh et al. , 2004 -RRB-	5654
a reorganization	5654
synaptic circuitry controlling the activity of sympathetic preganglionic neurons -LRB- Llewellyn-Smith , 2009 ; Maiorov et al. , 1997a ; Maiorov et al. , 1997b ; Marsh et al. , 2004 -RRB-	5674
synaptic circuitry	5674
the activity of sympathetic preganglionic neurons -LRB- Llewellyn-Smith , 2009 ; Maiorov et al. , 1997a ; Maiorov et al. , 1997b ; Marsh et al. , 2004 -RRB-	5705
the activity	5705
sympathetic preganglionic neurons -LRB- Llewellyn-Smith , 2009 ; Maiorov et al. , 1997a ; Maiorov et al. , 1997b ; Marsh et al. , 2004 -RRB-	5721
sympathetic preganglionic neurons	5721
Llewellyn-Smith , 2009 ; Maiorov et al. , 1997a ; Maiorov et al. , 1997b ; Marsh et al. , 2004	5756
Llewellyn-Smith	5756
2009 ; Maiorov et al. , 1997a ; Maiorov et al. , 1997b ; Marsh et al.	5773
2009	5773
Maiorov et al. , 1997a ; Maiorov et al. , 1997b ; Marsh et al.	5779
Maiorov	5779
et al. , 1997a ; Maiorov et al. , 1997b ; Marsh et al.	5787
et al. , 1997a	5787
et al.	5787
1997a	5795
Maiorov et al. , 1997b	5802
Maiorov	5802
et al. , 1997b	5810
et al.	5810
1997b	5818
Marsh et al.	5825
Marsh	5825
et al.	5831
2004	5839
the reduction in severity of autonomic dysreflexia by OEC transplantation	5856
the reduction	5856
severity of autonomic dysreflexia by OEC transplantation	5873
severity	5873
autonomic dysreflexia by OEC transplantation	5885
autonomic dysreflexia	5885
OEC transplantation	5910
a reorganization in synaptic inputs as well as changes in the morphology of sympathetic preganglionic neurons	5942
a reorganization in synaptic inputs	5942
a reorganization	5942
synaptic inputs	5962
changes in the morphology of sympathetic preganglionic neurons	5989
changes	5989
the morphology of sympathetic preganglionic neurons	6000
the morphology	6000
sympathetic preganglionic neurons	6018
The second aim of the present study	6053
The second aim	6053
the present study	6071
the density of synapses on the somata of sympathetic preganglionic neurons	6105
the density	6105
synapses on the somata of sympathetic preganglionic neurons	6120
synapses	6120
the somata of sympathetic preganglionic neurons	6132
the somata	6132
sympathetic preganglionic neurons	6146
OEC transplantation with the hypothesis that the reduction of autonomic dysreflexia requires synaptic changes as well as the morphologic changes as previously observed -LRB- Kalincik et al. , 2010a ; Kalincik et al. , 2010b -RRB-	6186
OEC transplantation	6186
the hypothesis that the reduction of autonomic dysreflexia requires synaptic changes as well as the morphologic changes as previously observed -LRB- Kalincik et al. , 2010a ; Kalincik et al. , 2010b -RRB-	6211
the hypothesis that the reduction of autonomic dysreflexia requires synaptic changes	6211
the hypothesis	6211
the reduction of autonomic dysreflexia	6231
the reduction	6231
autonomic dysreflexia	6248
synaptic changes	6279
the morphologic changes as previously observed -LRB- Kalincik et al. , 2010a ; Kalincik et al. , 2010b -RRB-	6307
the morphologic changes	6307
Kalincik	6355
et al. , 2010a ; Kalincik et al. , 2010b	6364
et al.	6364
2010a ; Kalincik et al.	6372
2010a	6372
Kalincik et al.	6379
Kalincik	6379
et al.	6388
2010b	6396
Previous studies	6404
the cell type-specificity effects of olfactory ensheathing cells	6439
the cell type-specificity effects	6439
olfactory ensheathing cells	6476
them	6517
a fibroblasts transplanted group as a control -LRB- Khankan et al. , 2016 ; Toft et al. , 2013 -RRB-	6527
a fibroblasts	6527
transplanted group as a control -LRB- Khankan et al. , 2016 ; Toft et al. , 2013 -RRB-	6541
transplanted group	6541
a control -LRB- Khankan et al. , 2016 ; Toft et al. , 2013 -RRB-	6563
a control	6563
Khankan	6574
et al. , 2016 ; Toft et al. , 2013	6582
et al.	6582
2016 ; Toft et al.	6590
2016	6590
Toft et al.	6596
Toft	6596
et al.	6601
2013	6609
a third aim	6619
we	6632
the changes in autonomic dysreflexia , sympathetic preganglionic neurons morphology and the density of synapses on the somata of sympathetic preganglionic neuronswere specific to olfactory ensheathing cells and not induced by fibroblasts -LRB- control group -RRB-	6658
the changes	6658
autonomic dysreflexia , sympathetic preganglionic neurons morphology and the density of synapses on the somata of sympathetic preganglionic neuronswere specific to olfactory ensheathing cells and not induced by fibroblasts -LRB- control group -RRB-	6673
autonomic dysreflexia	6673
sympathetic preganglionic neurons morphology	6696
the density of synapses on the somata of sympathetic preganglionic neuronswere specific to olfactory ensheathing cells and not induced by fibroblasts -LRB- control group -RRB-	6745
the density	6745
synapses on the somata of sympathetic preganglionic neuronswere	6760
synapses	6760
the somata of sympathetic preganglionic neuronswere	6772
the somata	6772
sympathetic preganglionic neuronswere	6786
olfactory ensheathing cells	6836
fibroblasts -LRB- control group -RRB-	6883
fibroblasts	6883
control group	6896
response	6928
cell transplantation	6940
Materials andmethods 2.1 .	6966
Materials andmethods	6966
2.1	6987
Animals Experiments	6992
24 adult male Australian inbred Wistar rats -LRB- Biological Resource Centre , Sydney , New South Wales -RRB- -LRB- 350 -- 400 g -RRB-	7030
24 adult male Australian inbred Wistar rats -LRB- Biological Resource Centre , Sydney , New South Wales -RRB-	7030
24 adult male Australian inbred Wistar rats	7030
Biological Resource Centre , Sydney , New South Wales	7075
Biological Resource Centre	7075
Sydney	7103
New South Wales	7111
350 -- 400 g	7129
350	7129
400 g	7133
They	7141
individual plastic home boxes -LRB- 65 × 40 × 22 cm -RRB- with ad libitum food and water	7161
65 × 40 × 22 cm	7192
65 × 40 ×	7192
65 ×	7192
40 ×	7197
22 cm	7202
ad libitum food	7214
a 12/12 h light/dark cycle	7258
All experimental procedures	7286
the Animal Care and Ethics Committees of the University of New South Wales and Griffith University in accordance	7331
the Animal Care and Ethics Committees	7331
the University of New South Wales and Griffith University in accordance	7372
the University	7372
New South Wales and Griffith University in accordance	7390
New South Wales and Griffith University	7390
accordance	7433
guidelines of the National Health and Medical Research Council of Australia	7449
guidelines of the National Health	7449
guidelines	7449
the National Health	7463
Medical Research Council of Australia	7487
Medical Research Council	7487
Australia	7515
2.2	7526
Biopsy and culture of olfactory ensheathing cells and fibroblasts Six adult male albino Australian inbred Wistar rats -LRB- Biological Resource Centre , Sydney , New South Wales -RRB- -LRB- 350 -- 400 g -RRB-	7531
Biopsy and culture	7531
olfactory ensheathing cells and fibroblasts Six adult male albino Australian inbred Wistar rats -LRB- Biological Resource Centre , Sydney , New South Wales -RRB- -LRB- 350 -- 400 g -RRB-	7553
olfactory ensheathing cells and fibroblasts Six adult male albino Australian inbred Wistar rats -LRB- Biological Resource Centre , Sydney , New South Wales -RRB-	7553
olfactory ensheathing cells and fibroblasts Six adult male albino Australian inbred Wistar rats	7553
olfactory ensheathing cells and fibroblasts	7553
Six adult male albino Australian inbred Wistar rats	7597
Biological Resource Centre , Sydney , New South Wales	7650
Biological Resource Centre	7650
Sydney	7678
New South Wales	7686
350 -- 400 g	7704
350	7704
400 g	7708
harvesting and culture of OECs and fibroblasts	7729
harvesting and culture	7729
OECs and fibroblasts	7755
These rats	7777
pentobarbitone -LRB- 0.5 ml intraperitoneally ; Lethabarb , Virbac Pty. Ltd. , NSW , Australia -RRB-	7819
pentobarbitone	7819
0.5 ml intraperitoneally ; Lethabarb , Virbac Pty. Ltd. , NSW , Australia	7835
0.5 ml intraperitoneally ; Lethabarb , Virbac Pty. Ltd. ,	7835
0.5 ml intraperitoneally	7835
0.5 ml	7835
Lethabarb , Virbac Pty. Ltd. ,	7861
Lethabarb	7861
Virbac Pty. Ltd.	7872
NSW , Australia	7890
decapitation	7920
OECswere	7934
fromthe olfactory mucosa of rats in the samemanner as previously described -LRB- Bianco et al. , 2004 -RRB-	7952
fromthe olfactory mucosa	7952
rats in the samemanner as previously described -LRB- Bianco et al. , 2004 -RRB-	7980
rats	7980
the samemanner as previously described -LRB- Bianco et al. , 2004 -RRB-	7988
the samemanner	7988
Bianco	8028
et al. , 2004	8035
et al.	8035
2004	8043
Isolation and purification of the OECS	8050
Isolation and purification	8050
the OECS	8080
the same manner as previously described -LRB- Kalincik et al. , 2010a -RRB-	8107
the same manner	8107
Kalincik	8148
et al. , 2010a	8157
et al.	8157
2010a	8165
Primary cultures of fibroblasts from the same strain of rat	8173
Primary cultures	8173
fibroblasts from the same strain of rat	8193
fibroblasts	8193
the same strain of rat	8210
the same strain	8210
rat	8229
skin biopsies	8253
published protocol -LRB- Matigian et al. , 2008 -RRB-	8280
published protocol	8280
Matigian	8300
et al. , 2008	8309
et al.	8309
2008	8317
Only OECs	8324
humanised Renilla green fluorescent protein as described previously -LRB- Gorrie et al. , 2010 -RRB-	8359
humanised Renilla	8359
green fluorescent protein as described previously -LRB- Gorrie et al. , 2010 -RRB-	8377
green fluorescent protein	8377
Gorrie	8428
et al. , 2010	8435
et al.	8435
2010	8443
OECs and fibroblasts	8450
tissue culture flasks as described previously -LRB- Gorrie et al. , 2010 -RRB-	8495
tissue culture flasks	8495
Gorrie	8542
et al. , 2010	8549
et al.	8549
2010	8557
2.3	8564
Spinal cord transection and cell transplantation Eighteen ratswere anaesthetisedwith a mixture of ketamine hydrochloride -LRB- 100 mg kg − 1 intraperitoneally ; Ketamine , Parnell Laboratories Pty. Ltd. , NSW , Australia -RRB- and xylazine -LRB- 7 mg kg − 1 , intraperitoneally ; Ilium Xylazil-20 , Troy Laboratories Pty. Ltd. , NSW , Australia -RRB- .	8569
Spinal cord transection and cell transplantation	8569
Eighteen ratswere anaesthetisedwith a mixture	8618
Eighteen ratswere anaesthetisedwith	8618
a mixture	8654
ketamine hydrochloride -LRB- 100 mg kg − 1 intraperitoneally ; Ketamine , Parnell Laboratories Pty. Ltd. , NSW , Australia -RRB- and xylazine -LRB- 7 mg kg − 1 , intraperitoneally ; Ilium Xylazil-20 , Troy Laboratories Pty. Ltd. , NSW , Australia -RRB-	8667
ketamine hydrochloride	8667
100 mg kg − 1 intraperitoneally ; Ketamine , Parnell Laboratories Pty. Ltd. , NSW , Australia	8691
100 mg kg −	8691
1 intraperitoneally ; Ketamine , Parnell Laboratories Pty. Ltd. , NSW , Australia	8701
1 intraperitoneally	8701
1	8701
Ketamine , Parnell Laboratories Pty. Ltd. , NSW , Australia	8722
Ketamine	8722
Parnell Laboratories Pty. Ltd.	8732
NSW	8764
Australia	8769
xylazine	8784
7 mg kg − 1 , intraperitoneally ; Ilium Xylazil-20 , Troy Laboratories Pty. Ltd. , NSW , Australia	8794
7 mg	8794
kg − 1 , intraperitoneally ; Ilium Xylazil-20 , Troy Laboratories Pty. Ltd. , NSW , Australia	8799
kg − 1 , intraperitoneally	8799
kg −	8799
1	8802
Ilium Xylazil-20 , Troy Laboratories Pty. Ltd. , NSW , Australia	8824
Ilium Xylazil-20	8824
Troy Laboratories Pty. Ltd.	8842
NSW	8871
Australia	8876
Laminectomy of the T3 vertebra	8888
Laminectomy	8888
the T3 vertebra	8903
the T4 spinal segment like described previously -LRB- Kalincik et al. , 2010a -RRB-	8943
the T4 spinal segment	8943
Kalincik	8992
et al. , 2010a	9001
et al.	9001
2010a	9009
immobilization of the spinal process rostral to the laminectomy site	9023
immobilization	9023
the spinal process rostral to the laminectomy site	9041
the spinal process rostral	9041
the laminectomy site	9071
GFP-OECs -LRB- n = 9 animals -RRB-	9093
GFP-OECs	9093
n	9103
9 animals	9107
a sterile 10 μl Hamilton syringe -LRB- Hamilton , Reno , NV -RRB-	9154
a sterile 10 μl Hamilton syringe	9154
10 μl	9164
Hamilton	9188
Reno	9198
NV	9204
a silicon-coated	9213
glass tip	9237
inner diameter of 80 -- 100 μm	9253
inner diameter of 80	9253
inner diameter	9253
80	9271
100 μm	9275
Rats -LRB- n = 9 -RRB-	9284
Rats	9284
n	9290
9	9294
four injections of GFP-OECs -LRB- 0.5 μl of 100,000 cells/μl , in culture medium DMEM/F12 -RRB- , two injections 2 mm cranial and two 2 mm caudal to the future lesion site , each 0.5 mm lateral	9306
four injections of GFP-OECs -LRB- 0.5 μl of 100,000 cells/μl , in culture medium DMEM/F12 -RRB-	9306
four injections	9306
GFP-OECs -LRB- 0.5 μl of 100,000 cells/μl , in culture medium DMEM/F12 -RRB-	9325
GFP-OECs	9325
0.5 μl of 100,000 cells/μl , in culture medium DMEM/F12	9335
0.5 μl	9335
100,000 cells/μl	9345
culture medium DMEM/F12	9366
two injections 2 mm cranial	9392
two injections	9392
2 mm cranial	9407
two 2 mm caudal to the future lesion site , each 0.5 mm lateral	9424
two 2 mm caudal	9424
the future lesion site , each 0.5 mm lateral	9443
the future lesion site	9443
each 0.5 mm lateral	9467
the midline	9490
0.8 mm	9505
each injection	9522
the needle	9538
situ for 1	9561
situ	9561
1	9570
2 min	9572
reflux	9589
Control animals -LRB- n = 9 -RRB-	9597
Control animals	9597
n	9614
9	9618
fibroblasts	9630
similar concentrations	9645
The spinal cord	9669
microscissors between the two pairs of injection sites	9721
microscissors	9721
the two pairs of injection sites	9743
the two pairs	9743
injection sites	9760
Complete transection	9777
a scalpel blade and observation	9817
a scalpel blade	9817
observation	9837
the dissecting microscope	9855
transection , a gap of approximately 1	9892
transection	9892
a gap of approximately 1	9905
a gap	9905
approximately 1	9914
2 mm	9930
the rostral and caudal ends of the cord	9955
the rostral and caudal ends	9955
the cord	9986
a piece of absorbable gelatin sponge -LRB- SPONGOSTAN ® , Johnson and Johnson medical limited , Sipton , U.K. -RRB-	9999
a piece	9999
absorbable gelatin sponge -LRB- SPONGOSTAN ® , Johnson and Johnson medical limited , Sipton , U.K. -RRB-	10010
absorbable gelatin sponge	10010
SPONGOSTAN ® , Johnson and Johnson medical limited , Sipton , U.K.	10037
SPONGOSTAN ®	10037
Johnson	10050
Johnson medical limited , Sipton , U.K.	10062
Johnson medical limited , Sipton ,	10062
U.K.	10095
the gap	10122
bleeding	10141
Another piece of absorbable gelatin sponge	10151
Another piece	10151
absorbable gelatin sponge	10168
the dorsal surface of the cord	10213
the dorsal surface	10213
the cord	10235
the muscle tissue and skin	10248
layers	10291
surgery	10317
the rats	10326
the muscarinic cholinoceptor antagonist atropine methyl nitrate -LRB- 3 mg kg − 1 subcutaneously ; Sigma , St. Louis , MO , USA -RRB-	10344
the muscarinic cholinoceptor antagonist atropine methyl nitrate	10344
3 mg kg − 1 subcutaneously ; Sigma , St. Louis , MO , USA	10409
3 mg kg −	10409
1 subcutaneously ; Sigma , St. Louis , MO , USA	10417
1 subcutaneously	10417
1	10417
Sigma , St. Louis , MO , USA	10435
Sigma	10435
St. Louis	10442
MO	10453
USA	10457
An antibiotic -LRB- Cephalothin , 30 mg kg − 1 subcutaneously ; VIC , Australia -RRB-	10463
An antibiotic	10463
Cephalothin , 30 mg kg − 1 subcutaneously ; VIC , Australia	10478
Cephalothin	10478
30 mg kg − 1 subcutaneously ; VIC	10491
30 mg kg − 1 subcutaneously	10491
30 mg kg −	10491
1 subcutaneously	10500
1	10500
VIC	10518
Australia	10523
there	10574
no sign of urinary infection -LRB- noted by cloudiness of expressed urine -RRB- for three consecutive days	10584
no sign	10584
urinary infection	10595
cloudiness of expressed urine	10623
cloudiness	10623
expressed urine	10637
three consecutive days	10658
Animals	10682
an analgesic -LRB- Carprofen , 50 mg kg − 1 subcutaneously ; Australia Pty. Ltd. , Australia -RRB-	10704
an analgesic	10704
Carprofen , 50 mg kg − 1 subcutaneously ; Australia Pty. Ltd. , Australia	10718
Carprofen	10718
50 mg kg − 1 subcutaneously ; Australia Pty. Ltd.	10729
50 mg kg − 1 subcutaneously	10729
50 mg kg −	10729
1 subcutaneously	10738
1	10738
Australia Pty. Ltd.	10756
Australia	10777
2 -- 3 days	10798
2	10798
3 days	10800
Lactated Hartmann 's solution -LRB- 5 -- 10 ml subcutaneously ; Baxter Healthcare Pty. Ltd. .	10808
Lactated Hartmann 's solution -LRB- 5 -- 10 ml subcutaneously	10808
Lactated Hartmann 's	10808
solution -LRB- 5 -- 10 ml subcutaneously	10828
solution	10828
5 -- 10 ml subcutaneously	10838
5 -- 10	10838
ml subcutaneously	10843
ml	10843
Baxter Healthcare Pty. Ltd.	10862
Sydney	10890
Australia	10898
2 -- 3 times daily until the rats were able to drink normally	10926
2	10926
3 times	10928
the rats	10948
Manual emptying of the urinary bladder	10986
Manual emptying	10986
the urinary bladder	11005
3 times a day	11041
3 times	11041
a day	11049
the rats	11061
a micturition reflex -LRB- ~ 2 weeks -RRB-	11080
a micturition reflex	11080
~ 2 weeks	11102
~	11102
2 weeks	11103
The room temperature	11113
27 -- 28 °C for the first 1	11152
27	11152
28 °C for the first 1	11155
28 °C	11155
the first 1	11165
2 weeks and rat core temperature	11177
2 weeks	11177
rat core temperature	11189
normal temperature	11239
The room temperature	11274
26 °C	11313
the end of the experiment	11325
the end	11325
the experiment	11336
2.4	11352
Implantation of radio-telemetric probes Four weeks	11357
Implantation	11357
radio-telemetric probes	11373
Four weeks	11397
spinal cord transection	11414
the rats	11439
radio-telemetric probes -LRB- PA-C40 , Data Sciences International St. Paul , MN , USA . -RRB-	11480
radio-telemetric probes	11480
PA-C40 , Data Sciences International St. Paul , MN , USA .	11505
PA-C40	11505
Data Sciences International St. Paul	11513
MN	11551
USA .	11555
the measurement of the mean arterial pressure and heart rate as described previously -LRB- Cloutier et al. , 2010 -RRB-	11565
the measurement	11565
the mean arterial pressure and heart rate as described previously -LRB- Cloutier et al. , 2010 -RRB-	11584
the mean	11584
arterial pressure and heart rate	11593
Cloutier	11651
et al. , 2010	11660
et al.	11660
2010	11668
2.5	11675
Induction of autonomic dysreflexia	11680
Induction	11680
autonomic dysreflexia	11693
Colorectal distensions were carried out at 6 , 7 and 8 weeks after the spinal cord injury and performed as described previously	11715
Colorectal distensions	11715
6 , 7 and 8	11758
weeks	11769
the spinal cord injury	11781
Kalincik et al. , 2010a	11843
Kalincik	11843
et al.	11852
2010a	11860
The average response	11868
three distensions made during the recording period	11909
three distensions	11909
the recording period	11939
The entire cardiovascular response to colorectal distensions , including a 10 min period following the distension ,	11961
The entire cardiovascular response	11961
colorectal distensions	11999
a 10 min period following the distension	12033
a 10 min period	12033
the distension	12059
the average peak changes in mean arterial pressure and heart rate	12092
the average peak changes	12092
mean arterial pressure and heart rate	12120
2.6	12175
Radio-telemetric recording At least half an hour prior to recording resting cardiovascular parameters and colorectal distension responses , radio-telemetric probes	12180
Radio-telemetric recording	12180
At least half an hour	12207
At least half	12207
an hour	12221
recording resting cardiovascular parameters and colorectal distension responses , radio-telemetric probes	12238
recording	12238
cardiovascular parameters and colorectal distension responses , radio-telemetric probes	12256
cardiovascular parameters	12256
colorectal distension responses , radio-telemetric probes	12286
colorectal distension responses	12286
radio-telemetric probes	12319
Mean arterial pressure and heart rate	12359
Mean arterial pressure	12359
heart rate	12386
3 s	12416
every 10 s via a data acquisition package -LRB- Dataquest ART , Data Sciences International St. Paul , MN , USA -RRB-	12420
every 10 s	12420
a data acquisition package -LRB- Dataquest ART , Data Sciences International St. Paul , MN , USA -RRB-	12435
a data acquisition package	12435
Dataquest ART , Data Sciences International St. Paul , MN , USA	12463
Dataquest ART	12463
Data Sciences International St. Paul	12478
MN	12516
USA	12520
Resting cardiovascular parameters	12526
a 20 min period	12579
rats	12602
rest in their home cage	12615
rest	12615
their home cage	12623
The average mean arterial pressure and heart rate for each rat	12640
The average mean arterial pressure	12640
heart rate for each rat	12679
heart rate	12679
each rat	12694
the entire 20 min period	12728
comparison , resting cardiovascular parameters	12758
comparison	12758
cardiovascular parameters	12778
arterial pressure and heart rate	12810
arterial pressure	12810
heart rate	12832
a group of 6 adult male AAWrats	12861
a group	12861
6 adult male AAWrats	12872
spinal cord injury	12901
Colorectal distensions response recordings	12921
the experimental animals with the same settings	12979
the experimental animals	12979
the same settings	13009
The following values	13028
recorded mean arterial pressure and heart rate	13069
recorded mean arterial pressure	13069
heart rate	13105
i	13118
relativemean arterial pressure and heart rate , which represent deviations from baseline -LRB- obtained as averages of 8 measurements prior to colorectal distension -RRB-	13121
relativemean arterial pressure	13121
heart rate , which represent deviations from baseline -LRB- obtained as averages of 8 measurements prior to colorectal distension -RRB-	13156
heart rate , which represent deviations from baseline	13156
heart rate	13156
deviations	13183
baseline	13199
averages of 8 measurements prior to colorectal distension	13221
averages	13221
8 measurements prior to colorectal distension	13233
8 measurements	13233
colorectal distension	13257
ii	13282
max	13286
arterial pressure and max heart rate , whichwere defined as the maximal relative changes in mean arterial pressure and heart rate recorded in a rat during autonomic dysreflexia	13295
arterial pressure and max heart rate	13295
whichwere defined as the maximal relative changes in mean arterial pressure and heart rate recorded in a rat during autonomic dysreflexia	13332
whichwere	13332
the maximal relative changes	13353
mean arterial pressure and heart rate recorded in a rat during autonomic dysreflexia	13385
mean arterial pressure	13385
heart rate recorded in a rat during autonomic dysreflexia	13412
heart rate	13412
a rat	13435
autonomic dysreflexia	13448
T50	13477
arterial pressure , which represent the time taken for the mean arterial pressure response to decrease to 50 % of its peak value	13486
arterial pressure	13486
the time taken for the mean arterial pressure response to decrease to 50 % of its peak value	13521
the time	13521
the mean arterial pressure response	13540
50 % of its peak value	13591
50 %	13591
its peak value	13598
2.7	13614
Histochemistry , immunofluorescence and image analysis Nineweeks after cell transplantation	13619
Histochemistry , immunofluorescence and image analysis Nineweeks	13619
Histochemistry , immunofluorescence and image analysis	13619
cell transplantation	13689
anaesthesiawith	13717
a combination of ketamine and xylazine as above , radio-telemetric probes	13733
a combination	13733
ketamine and xylazine as above , radio-telemetric probes	13750
ketamine and xylazine	13750
above , radio-telemetric probes	13775
the femoral artery ligated	13823
the femoral artery	13823
Animalswere then terminally anaesthetizedwith sodiumpentobarbitone -LRB- Nembutal ; 80mg/ml , IP -RRB- and transcardially	13851
Animalswere	13851
then terminally anaesthetizedwith sodiumpentobarbitone -LRB- Nembutal ; 80mg/ml , IP -RRB-	13863
then	13863
terminally anaesthetizedwith sodiumpentobarbitone -LRB- Nembutal ; 80mg/ml , IP -RRB-	13868
terminally anaesthetizedwith sodiumpentobarbitone	13868
Nembutal ; 80mg/ml , IP	13919
Nembutal	13919
80mg/ml , IP	13929
80mg/ml	13929
IP	13938
50 ml of physiological heparinized saline followed by 500 ml of 4 % paraformaldehyde -LRB- Fisher Scientific , Pittsburgh , PA , USA -RRB- in 0.1 M phosphate buffer pH 7.4	13975
50 ml	13975
physiological heparinized saline followed by 500 ml of 4 % paraformaldehyde -LRB- Fisher Scientific , Pittsburgh , PA , USA -RRB- in 0.1 M phosphate buffer pH 7.4	13984
physiological heparinized saline	13984
500 ml of 4 % paraformaldehyde -LRB- Fisher Scientific , Pittsburgh , PA , USA -RRB-	14029
500 ml	14029
4 % paraformaldehyde -LRB- Fisher Scientific , Pittsburgh , PA , USA -RRB-	14039
4 % paraformaldehyde	14039
Fisher Scientific , Pittsburgh , PA , USA	14060
Fisher Scientific	14060
Pittsburgh	14079
PA	14091
USA	14095
0.1 M phosphate buffer pH 7.4	14103
0.1 M phosphate buffer	14103
pH 7.4	14126
Spinal cord regions extending 1 cm above and 1 cm below the injection/injury site	14134
Spinal cord regions	14134
1 cm above and 1 cm	14164
1 cm	14164
and 1 cm	14175
the injection/injury site	14190
post fixed in the same fixative overnight and then transferred into a solution of 30 % sucrose in 0.1 Mphosphate buffer	14232
post	14232
the same fixative overnight	14246
a solution of 30 % sucrose in 0.1 Mphosphate buffer	14300
a solution	14300
30 % sucrose in 0.1 Mphosphate buffer	14314
30 % sucrose	14314
0.1 Mphosphate buffer	14329
The spinal cords	14351
35 μm with a cryostat	14399
35 μm	14399
a cryostat	14410
gelatin-coated slides	14438
series of four	14463
series	14463
four	14473
− 22 °C	14503
NADPH-diaphorase staining of sympathetic preganglionic neurons	14511
NADPH-diaphorase staining	14511
sympathetic preganglionic neurons	14540
Carrive et al. , 1994 ; Kalincik et al. , 2010a ; Vincent et al. , 1992	14615
Carrive	14615
et al. , 1994 ; Kalincik et al. , 2010a ; Vincent et al. , 1992	14623
et al. , 1994	14623
et al.	14623
1994	14631
Kalincik et al. , 2010a	14637
Kalincik	14637
et al. , 2010a	14646
et al.	14646
2010a	14654
Vincent et al. , 1992	14661
Vincent	14661
et al. , 1992	14669
et al.	14669
1992	14677
immunofluorescence	14688
pretreatment with phosphate-buffered saline triton	14714
pretreatment	14714
phosphate-buffered saline triton	14732
cryostat sections	14766
4 °C with primary antibodies goat anti-choline acetyltransferase -LRB- 1:100 , Chemicon , Temecula , CA , USA -RRB- and rabbit anti-synaptophysin -LRB- 1:200 , Dako -RRB-	14812
4 °C	14812
primary antibodies goat anti-choline acetyltransferase -LRB- 1:100 , Chemicon , Temecula , CA , USA -RRB- and rabbit anti-synaptophysin -LRB- 1:200 , Dako -RRB-	14821
primary antibodies goat anti-choline acetyltransferase -LRB- 1:100 , Chemicon , Temecula , CA , USA -RRB-	14821
primary antibodies	14821
goat anti-choline acetyltransferase -LRB- 1:100 , Chemicon , Temecula , CA , USA -RRB-	14840
goat anti-choline acetyltransferase	14840
1:100	14877
Chemicon , Temecula	14884
CA , USA	14904
rabbit anti-synaptophysin -LRB- 1:200 , Dako -RRB-	14917
rabbit anti-synaptophysin	14917
1:200	14944
Dako	14951
Donkey anti-goat and mouse antirabbit secondary antibodies -LRB- Alexa Fluor 488 or 594 , Molecular Probes , Eugene , OR , USA -RRB-	14958
Donkey anti-goat and mouse antirabbit secondary antibodies	14958
Donkey anti-goat and mouse antirabbit	14958
Donkey	14958
anti-goat and mouse antirabbit	14965
Alexa Fluor	15018
488 or 594 , Molecular Probes , Eugene , OR , USA	15030
488 or 594	15030
Molecular Probes	15042
Eugene	15060
OR	15068
USA	15072
a dilution of 1:200	15090
a dilution	15090
1:200	15104
10 % normal goat serumin phosphate-buffered saline	15113
10 %	15113
2 h of incubation	15170
2 h	15170
incubation	15177
all sections	15189
phosphate-buffered saline	15217
5 min at room temperature in Hoechst solution	15261
5 min	15261
room temperature in Hoechst solution	15270
room temperature	15270
Hoechst solution	15290
1:5000 in phosphate-buffered saline	15308
1:5000	15308
phosphate-buffered saline	15318
Molecular Probes , Eugene , OR , USA	15345
Molecular Probes	15345
Eugene	15363
OR	15371
USA	15375
Standard immunohistochemical controls	15381
each run	15436
Images	15446
an Olympus FV1000 confocal microscope equipped with 405 , 488 , 543 nm lasers and a UPLSAPO 60 × O objective with a numerical aperture of 1.35	15473
an Olympus FV1000 confocal microscope	15473
405 , 488 , 543 nm lasers and a UPLSAPO 60 × O objective	15525
405	15525
488	15530
543 nm lasers	15535
a UPLSAPO 60 × O objective	15553
a UPLSAPO	15553
60 × O objective	15563
a numerical aperture of 1.35	15584
a numerical aperture	15584
1.35	15608
Imaging variables -LRB- laser power , pinhole , detector gain and dwell time -RRB-	15614
Imaging variables	15614
laser power , pinhole , detector gain and dwell time	15633
laser power	15633
pinhole	15646
detector gain and dwell time	15655
all images	15708
Each image	15720
three fluorescent channels : Red -LRB- anti-choline acetyltransferase , to identify the sympathetic preganglionic neurons -RRB- , green -LRB- anti-synaptophysin , to identify synaptic boutons -RRB- and blue -LRB- DAPI , to identify nuclei -RRB-	15744
three fluorescent channels : Red -LRB- anti-choline acetyltransferase , to identify the sympathetic preganglionic neurons -RRB-	15744
three fluorescent channels	15744
Red -LRB- anti-choline acetyltransferase , to identify the sympathetic preganglionic neurons	15772
Red	15772
-LRB- anti-choline acetyltransferase , to identify the sympathetic preganglionic neurons	15776
-LRB- anti-choline acetyltransferase ,	15776
the sympathetic preganglionic neurons	15821
green -LRB- anti-synaptophysin , to identify synaptic boutons -RRB-	15861
green	15861
anti-synaptophysin , to identify synaptic boutons	15868
anti-synaptophysin	15868
synaptic boutons	15900
blue -LRB- DAPI , to identify nuclei -RRB-	15922
blue	15922
DAPI , to identify nuclei	15928
DAPI	15928
nuclei	15946
3D optical sectioning through the tissue	15960
3D optical sectioning	15960
the tissue	15990
single optical sections of sympathetic preganglionic neurons -LRB- red channel -RRB-	16002
single optical sections	16002
sympathetic preganglionic neurons -LRB- red channel -RRB-	16029
sympathetic preganglionic neurons	16029
red channel	16064
the central plane of the nucleus -LRB- blue channel -RRB-	16109
the central plane	16109
the nucleus -LRB- blue channel -RRB-	16130
the nucleus	16130
blue channel	16143
the red cell cytoplasmcompletely	16173
the blue cell nucleus	16217
Basic Gaussian noise removal	16240
the red channel , followed by thresholding to produce a binary image	16291
the red channel	16291
a binary image	16344
Gaps in the red channel pixels that did not touch the border of the cell image	16360
Gaps	16360
the red channel pixels that did not touch the border of the cell image	16368
the red channel pixels	16368
the border of the cell image	16410
the border	16410
the cell image	16424
an initial cell mask	16461
a	16489
the initialmask	16509
a larger second cell mask	16548
the difference between the two masks	16580
the difference	16580
the two masks	16603
a 1.54 μm	16626
wide outline of the cell	16636
wide outline	16636
the cell	16652
This border	16662
cell area -LRB- μm2 -RRB-	16696
cell area	16696
μm2	16707
the number of synaptophysin positive pixels -LRB- green channel -RRB-	16725
the number	16725
synaptophysin positive pixels -LRB- green channel -RRB-	16739
synaptophysin positive pixels	16739
green channel	16770
2.8	16799
Morphometric analysis of sympathetic preganglionic neurons Morphological features of sympathetic preganglionic neurons in the injured spinal cords	16804
Morphometric analysis of sympathetic preganglionic neurons Morphological features	16804
Morphometric analysis of sympathetic preganglionic neurons	16804
Morphometric analysis	16804
sympathetic preganglionic neurons	16829
sympathetic preganglionic neurons in the injured spinal cords	16889
sympathetic preganglionic neurons	16889
the injured spinal cords	16926
Kalincik et al. , 2010a	16982
Kalincik	16982
et al.	16991
2010a	16999
Nine to ten sympathetic preganglionic neurons located rostrally -LRB- T2 -- T3 -RRB- and 9 -- 10 sympathetic preganglionic neurons located caudally -LRB- T5 -- T6 -RRB- to the injury site with clearly distinguishable perikarya and dendritic treeswere selected .	17007
Nine to ten sympathetic preganglionic neurons located rostrally -LRB- T2 -- T3 -RRB- and 9	17007
Nine	17007
ten sympathetic preganglionic neurons located rostrally -LRB- T2 -- T3 -RRB- and 9	17015
ten sympathetic preganglionic neurons located rostrally -LRB- T2 -- T3 -RRB-	17015
ten sympathetic preganglionic neurons	17015
T2 -- T3	17072
T2	17072
T3	17075
9	17083
10 sympathetic preganglionic neurons located caudally -LRB- T5 -- T6 -RRB- to the injury site with clearly distinguishable perikarya and dendritic treeswere selected	17085
10 sympathetic preganglionic neurons	17085
T5 -- T6	17140
T5	17140
T6	17143
the injury site with clearly distinguishable perikarya and dendritic treeswere selected	17150
the injury site with clearly distinguishable perikarya	17150
the injury site	17150
clearly distinguishable perikarya	17171
dendritic treeswere selected	17209
dendritic treeswere	17209
Threemorphological featureswere selected for analysis : area of soma , sum of lengths of all visible processes and number of primary dendrites .	17239
Threemorphological featureswere selected for analysis	17239
Threemorphological featureswere	17239
analysis	17284
area of soma , sum of lengths of all visible processes and number of primary dendrites	17294
area	17294
soma , sum of lengths of all visible processes and number of primary dendrites	17302
soma	17302
sum of lengths of all visible processes	17308
sum	17308
lengths of all visible processes	17315
lengths	17315
all visible processes	17326
number of primary dendrites	17352
number	17352
primary dendrites	17362
These	17381
ImageJ software	17407
2.9	17424
Statistical analysis The software packages StatView 5.0 -LRB- SAS Institute , Cary , NC , USA -RRB- , Prism 6.0 -LRB- La Jolla , CAL , USA -RRB- , and Statistica 10 -LRB- Statsoft , Tulsa	17429
Statistical analysis	17429
The software packages	17450
StatView 5.0 -LRB- SAS Institute , Cary , NC , USA -RRB- , Prism 6.0 -LRB- La Jolla , CAL , USA -RRB- , and Statistica 10 -LRB- Statsoft , Tulsa	17472
StatView 5.0 -LRB- SAS Institute , Cary , NC , USA -RRB-	17472
StatView 5.0	17472
SAS Institute	17486
Cary	17501
NC , USA	17507
Prism 6.0 -LRB- La Jolla , CAL , USA -RRB-	17517
Prism 6.0	17517
La Jolla	17528
CAL	17538
USA	17543
Statistica 10 -LRB- Statsoft , Tulsa	17553
Statistica 10	17553
Statsoft	17568
Tulsa	17578
USA	17589
statistical comparisons	17608
Baseline measurements of mean arterial pressure and heart rate	17633
Baseline measurements	17633
mean arterial pressure and heart rate	17658
mean arterial pressure	17658
heart rate	17685
one-way ANOVA	17713
treated and untreated animals followed by post-hoc comparisons with the Sidak test	17735
treated and untreated animals	17735
post-hoc comparisons	17777
the Sidak test	17803
Mean arterial pressure and heart rate measurements after colorectal distension	17819
Mean arterial pressure	17819
heart rate measurements after colorectal distension	17846
heart rate measurements	17846
colorectal distension	17876
repeated-measures ANOVA where the repeated measure was time fromthe onset of colorectal distension	17915
repeated-measures ANOVA	17915
the repeated measure	17945
time fromthe onset of colorectal distension	17970
time fromthe onset	17970
colorectal distension	17992
colorectal distention	18021
comparisons of Max	18044
comparisons	18044
Max	18059
arterial pressure , Max heart rate and T50	18068
arterial pressure	18068
Max heart rate	18087
T50	18106
arterial pressure between the two T4 transected groups	18115
arterial pressure	18115
the two T4 transected groups	18141
an unpaired Student 's t-test	18185
an unpaired Student 's	18185
Comparison of morphometric features and synaptic density of the sympathetic preganglionic neurons rostral and caudal to the injury in the OEC-transplanted group and fibroblast-transplanted groupwas	18215
Comparison of morphometric features	18215
Comparison	18215
morphometric features	18229
synaptic density of the sympathetic preganglionic neurons rostral and caudal to the injury in the OEC-transplanted group and fibroblast-transplanted groupwas	18255
synaptic density	18255
the sympathetic preganglionic neurons rostral and caudal to the injury in the OEC-transplanted group and fibroblast-transplanted groupwas	18275
the sympathetic preganglionic neurons rostral and caudal	18275
the injury in the OEC-transplanted group and fibroblast-transplanted groupwas	18335
the injury	18335
the OEC-transplanted group and fibroblast-transplanted groupwas	18349
the OEC-transplanted group	18349
fibroblast-transplanted groupwas	18380
a linear mixed model using a restricted maximum likelihood algorithm to estimate fixed and random effects -LRB- Kalincik et al. , 2010a ; Kalincik et al. , 2010b -RRB-	18430
a linear mixed model	18430
a restricted maximum likelihood algorithm	18457
fixed and random effects -LRB- Kalincik et al. , 2010a ; Kalincik et al. , 2010b -RRB-	18511
fixed and random effects	18511
Kalincik	18537
et al. , 2010a ; Kalincik et al. , 2010b	18546
et al.	18546
2010a ; Kalincik et al.	18554
2010a	18554
Kalincik et al.	18561
Kalincik	18561
et al.	18570
2010b	18578
The effect of treatment -LRB- OEC vs. fibroblast -RRB- and position -LRB- rostral vs. caudal to transection -RRB-	18586
The effect	18586
treatment -LRB- OEC vs. fibroblast -RRB- and position -LRB- rostral vs. caudal to transection -RRB-	18600
treatment	18600
OEC vs. fibroblast	18611
OEC	18611
fibroblast	18619
position	18635
rostral vs. caudal to transection	18645
rostral	18645
caudal to transection	18657
caudal	18657
transection	18667
the subject effect	18706
The model	18748
an interaction between treatment and position	18773
an interaction	18773
treatment and position	18796
Constant correlation	18820
all pairs of measurements in the same animal	18857
all pairs	18857
measurements in the same animal	18870
measurements	18870
the same animal	18886
Results	18907
1	18920
The recovery from hypertension induced by colorectal distension -LRB- duration indicated by ʻCRDʼ -RRB-	18923
The recovery	18923
hypertension induced by colorectal distension	18941
hypertension	18941
colorectal distension	18965
duration indicated by ʻCRDʼ	18988
duration	18988
ʻCRDʼ	19010
the GFP-OECs-transplanted group	19031
Relative changes in mean arterial pressure -LRB- A -RRB- and heart rate -LRB- B -RRB- during colorectal distention .	19064
Relative changes	19064
mean arterial pressure -LRB- A -RRB- and heart rate -LRB- B -RRB-	19084
mean arterial pressure	19084
A	19108
heart rate	19115
B	19127
colorectal distention	19137
Graphs	19160
averages of weeks 6 -- 8	19177
averages	19177
weeks 6 -- 8	19189
weeks	19189
6 -- 8	19195
no differences	19208
the heart rate response	19237
the mean arterial pressure response	19262
the mean	19262
arterial pressure response	19271
the groups -LRB- p = 0.013 , repeated measures ANOVA -RRB-	19329
the groups	19329
p = 0.013 , repeated measures ANOVA	19341
p	19341
0.013 , repeated measures ANOVA	19344
0.013	19344
measures	19360
ANOVA	19369
Recovery times T50 mean arterial pressures	19380
Recovery times	19380
T50	19395
arterial pressures	19404
GFPOECs - transplanted group for weeks 6 to 7	19453
GFPOECs	19453
transplanted group for weeks 6 to 7	19462
transplanted group	19462
weeks 6 to 7	19485
8 weeks following spinal cord injury	19509
8 weeks	19509
spinal cord injury	19527
All values	19547
the means	19568
p <	19591
p	19591
<	19593
0.05	19595
p <	19603
p	19603
<	19605
0.01	19607
Fig. 2 .	19614
Fig.	19614
2	19619
GFP-OECs	19622
9 weeks following spinal cord injury	19640
9 weeks	19640
spinal cord injury	19658
sympathetic preganglionic neurons	19699
Low magnification on longitudinal section	19734
Low magnification	19734
longitudinal section	19755
GFP-OECs clusters -LRB- arrowheads -RRB- easily distinguished by their green fluorescence -LRB- A -RRB-	19784
GFP-OECs clusters	19784
arrowheads	19803
their green fluorescence -LRB- A -RRB-	19839
their green fluorescence	19839
A	19865
A longitudinal section -LRB- similar anatomical reference as in A -RRB- stained for NADPH-diaphorase	19869
A longitudinal section -LRB- similar anatomical reference as in A -RRB-	19869
A longitudinal section	19869
similar anatomical reference as in A	19893
similar anatomical reference	19893
A	19928
NADPH-diaphorase	19943
sympathetic preganglionic neurons in the intermediolateral columns -LRB- arrows -RRB- -LRB- B -RRB-	19966
sympathetic preganglionic neurons	19966
the intermediolateral columns -LRB- arrows -RRB- -LRB- B -RRB-	20003
the intermediolateral columns -LRB- arrows -RRB-	20003
the intermediolateral columns	20003
arrows	20034
B	20043
OECs	20047
clusters or furrowed alongside the sympathetic preganglionic neurons columns	20087
clusters	20087
furrowed alongside the sympathetic preganglionic neurons columns	20099
the sympathetic preganglionic neurons	20118
Anti-Chat staining -LRB- red -RRB-	20165
Anti-Chat staining	20165
red	20185
a group of sympathetic preganglionic neurons -LRB- arrow -RRB-	20199
a group	20199
sympathetic preganglionic neurons -LRB- arrow -RRB-	20210
sympathetic preganglionic neurons	20210
arrow	20245
a column of GFP-OECs -LRB- arrowheads -RRB- -LRB- C -RRB-	20257
a column	20257
GFP-OECs -LRB- arrowheads -RRB- -LRB- C -RRB-	20269
GFP-OECs -LRB- arrowheads -RRB-	20269
GFP-OECs	20269
arrowheads	20279
C	20292
Confocal imaging	20296
the presence of GFP-OECs -LRB- arrowheads -RRB- close to a group of sympathetic preganglionic neurons -LRB- red , arrows -RRB- -LRB- D -RRB-	20324
the presence	20324
GFP-OECs -LRB- arrowheads -RRB- close to a group of sympathetic preganglionic neurons -LRB- red , arrows -RRB- -LRB- D -RRB-	20340
GFP-OECs	20340
arrowheads	20350
a group of sympathetic preganglionic neurons -LRB- red , arrows -RRB- -LRB- D -RRB-	20371
a group	20371
sympathetic preganglionic neurons -LRB- red , arrows -RRB- -LRB- D -RRB-	20382
sympathetic preganglionic neurons -LRB- red , arrows -RRB-	20382
sympathetic preganglionic neurons	20382
red , arrows	20417
red	20417
arrows	20422
D	20431
Fig. 3 .	20436
Fig.	20436
3	20441
The synaptic densities -LRB- green signal/red signal -RRB- on sympathetic preganglionic neurons somata	20444
The synaptic densities -LRB- green signal/red signal -RRB-	20444
The synaptic densities	20444
green signal/red signal	20468
sympathetic preganglionic neurons somata	20496
higher caudal	20542
the lesion in GFP-OECs-transplanted group	20559
the lesion	20559
GFP-OECs-transplanted group	20573
A : example of a sympathetic preganglionic neuron -LRB- red -RRB- with multiple synaptic contacts -LRB- arrows -RRB- caudal to the injury site in a GFP-OECs-transplanted rat .	20602
A : example of a sympathetic preganglionic neuron	20602
example of a sympathetic	20605
example	20605
a sympathetic	20616
red	20652
multiple synaptic contacts -LRB- arrows -RRB- caudal to the injury site in a GFP-OECs-transplanted rat	20662
multiple synaptic contacts	20662
arrows	20690
the injury site in a GFP-OECs-transplanted rat	20708
the injury site	20708
a GFP-OECs-transplanted rat	20727
B : example of a sympathetic preganglionic neuron with multiple synaptic contacts -LRB- arrows -RRB- caudal to the injury site in a fibroblasts-transplanted rat .	20756
B	20756
example of a sympathetic preganglionic neuron with multiple synaptic contacts -LRB- arrows -RRB- caudal to the injury site in a fibroblasts-transplanted rat	20759
example	20759
a sympathetic preganglionic neuron with multiple synaptic contacts -LRB- arrows -RRB- caudal to the injury site in a fibroblasts-transplanted rat	20770
a sympathetic preganglionic neuron	20770
multiple synaptic contacts -LRB- arrows -RRB- caudal to the injury site in a fibroblasts-transplanted rat	20810
multiple synaptic contacts	20810
arrows	20838
the injury site in a fibroblasts-transplanted rat	20856
the injury site	20856
a fibroblasts-transplanted rat	20875
Significant effects of both position and treatment were found -LRB- p ≤ 0.003 -RRB- -LRB- C -RRB- .	20907
Significant effects	20907
both position and treatment were found -LRB- p ≤ 0.003 -RRB- -LRB- C -RRB-	20930
both position and treatment were found -LRB- p ≤ 0.003 -RRB-	20930
both position and treatment	20930
p	20970
≤ 0.003	20972
C	20982
The experiment	20987
nine transected rats transplanted with GFP-OECs and nine transected rats transplanted with fibroblasts	21013
nine transected rats	21013
GFP-OECs and nine transected rats	21052
fibroblasts	21104
One GFP-OECs transplanted animal died immediately after the T4 transection .	21117
One GFP-OECs	21117
transplanted animal	21130
the T4 transection	21173
3.1	21193
OEC transplantation	21198
autonomic dysreflexia Colorectal distensions	21226
consistent autonomic dysreflexic responses 6 -- 8 weeks after spinal cord transection and transplantation of GFP-OECs or fibroblasts	21280
consistent autonomic dysreflexic responses 6 -- 8 weeks after spinal cord transection	21280
consistent autonomic dysreflexic responses 6	21280
consistent autonomic dysreflexic responses	21280
6	21323
8 weeks after spinal cord transection	21325
8 weeks	21325
spinal cord transection	21339
transplantation of GFP-OECs or fibroblasts	21367
transplantation	21367
GFP-OECs or fibroblasts	21386
both groups	21414
colorectal distensions	21427
amarked increase	21457
mean arterial pressure that peaked 80 -- 90 s after the start of the inflation of the Foley catheter and then gradually returned to baseline within 8 to 10 min -LRB- Fig. 1A -RRB-	21477
mean arterial pressure	21477
80 -- 90 s after the start of the inflation of the Foley catheter and then gradually returned to baseline within 8 to 10 min -LRB- Fig. 1A -RRB-	21512
80	21512
90 s after the start of the inflation of the Foley catheter and then gradually returned to baseline within 8 to 10 min -LRB- Fig. 1A -RRB-	21515
90 s	21515
the start of the inflation of the Foley catheter	21526
the start	21526
the inflation of the Foley catheter	21539
the inflation	21539
the Foley catheter	21556
baseline within 8 to 10 min -LRB- Fig. 1A -RRB-	21606
baseline	21606
8 to 10 min -LRB- Fig. 1A -RRB-	21622
8 to 10 min	21622
Fig. 1A	21634
This pressor response	21644
associatedwith a bradycardia -LRB- Fig. 1B -RRB-	21670
associatedwith a bradycardia	21670
associatedwith	21670
a bradycardia	21685
Fig. 1B	21700
A repeatedmeasure ANOVA performed on the first 10 min of the colorectal distensions	21710
A repeatedmeasure ANOVA	21710
the first 10 min of the colorectal distensions	21747
the first 10 min	21747
the colorectal distensions	21767
a significant treatment effect	21804
the GFP-OEC-transplanted group and the fibroblast-transplanted group	21843
the GFP-OEC-transplanted group	21843
the fibroblast-transplanted group	21878
the mean arterial pressure response -LRB- F -LRB- 1,15 -RRB- = 7.89 , p = 0.013 -RRB-	21916
the mean arterial pressure response	21916
F -LRB- 1,15 -RRB- = 7.89 , p	21953
F -LRB- 1,15 -RRB-	21953
F	21953
1,15	21955
7.89 , p	21961
7.89	21961
p	21967
0.013	21969
the heart rate response -LRB- F -LRB- 1,15 -RRB- = 0.75 ; p = 0.4 -RRB-	21989
the heart rate response	21989
F -LRB- 1,15 -RRB- = 0.75 ; p = 0.4	22014
F -LRB- 1,15 -RRB- = 0.75 ; p	22014
F -LRB- 1,15 -RRB- = 0.75	22014
F -LRB- 1,15 -RRB-	22014
F	22014
1,15	22016
0.75	22022
p	22028
= 0.4	22029
eachweekwas	22040
the treatment effect for mean arterial pressure	22077
the treatment effect	22077
mean arterial pressure	22102
week 6 -LRB- F -LRB- 1,15 -RRB- = 5.19 , p = 0.038 -RRB-	22144
week 6	22144
F -LRB- 1,15 -RRB- = 5.19 , p	22152
F -LRB- 1,15 -RRB-	22152
F	22152
1,15	22154
5.19 , p	22162
5.19	22162
p	22168
0.038	22172
significance	22200
weeks 7 and 8 -LRB- p N 0.06 -RRB-	22216
weeks 7 and 8	22216
p N 0.06	22231
p N	22231
0.06	22235
There	22242
no effect of treatment for heart rate	22252
no effect	22252
treatment for heart rate	22265
treatment	22265
heart rate	22279
weeks	22293
6 , 7 or 8	22299
p N 0.23	22339
p N	22339
0.23	22343
The faster recovery from hypertension	22350
The faster recovery	22350
hypertension	22375
a comparison of averaged T50 mean arterial pressure between the two groups -LRB- Fig. 1C -RRB-	22405
a comparison	22405
T50	22430
arterial pressure between the two groups -LRB- Fig. 1C -RRB-	22439
arterial pressure	22439
the two groups -LRB- Fig. 1C -RRB-	22465
the two groups	22465
Fig. 1C	22481
The average T50	22491
arterial pressure forweeks	22512
6 -- 8was reduced by 26 % in the GFP-OEC-transplanted group compared with the fibroblast-transplanted group -LRB- 104 ± 7 s vs. 142 ± 10 s , p = 0.01 , Fig. 1C -RRB-	22539
6 -- 8was	22539
26 % in the GFP-OEC-transplanted group	22557
26 %	22557
the GFP-OEC-transplanted group	22564
the fibroblast-transplanted group -LRB- 104 ± 7 s vs. 142 ± 10 s , p = 0.01 , Fig. 1C -RRB-	22609
the fibroblast-transplanted group	22609
104 ± 7 s vs. 142 ± 10 s , p = 0.01 , Fig. 1C	22644
104 ± 7 s vs. 142 ± 10 s	22644
104 ±	22644
7 s vs. 142 ± 10 s	22650
7 s	22650
142	22658
10 s	22664
p = 0.01	22670
p	22670
0.01	22674
Fig. 1C	22680
Fig.	22680
1C	22685
The same analysis on weeks 6 to 8	22690
The same analysis	22690
weeks 6 to 8	22711
a significant difference	22746
weeks 6 and 7 -LRB- p < 0.047 -RRB-	22774
weeks 6 and 7	22774
p < 0.047	22789
p	22789
< 0.047	22791
<	22791
0.047	22793
8 week -LRB- p = 0.17 -RRB- following spinal cord injury -LRB- Fig. 1C -RRB-	22811
8 week -LRB- p = 0.17 -RRB-	22811
8 week	22811
p	22819
0.17	22822
spinal cord injury	22838
Fig. 1C	22858
3.2	22868
OECs	22873
nine weeks after transplantation Nine weeks	22891
nine weeks	22891
transplantation	22908
Nine weeks	22924
transplantation	22941
the spinal cord	22962
GFP-OECs	22979
caudal and rostral	23005
the injury site in all animals	23027
the injury site	23027
all animals	23046
Low magnification on longitudinal sections	23059
Low magnification	23059
longitudinal sections	23080
GFP-OECs clusters -LRB- arrowheads -RRB- easily distinguished by their green fluorescence -LRB- Fig. 2A -RRB-	23111
GFP-OECs clusters	23111
arrowheads	23130
their green fluorescence -LRB- Fig. 2A -RRB-	23166
their green fluorescence	23166
Fig. 2A	23192
a reference	23205
a longitudinal section stained for NADPH-diaphorase	23218
a longitudinal section	23218
NADPH-diaphorase	23253
sympathetic preganglionic neurons in the intermediolateral columns -LRB- Fig. 2B -RRB-	23276
sympathetic preganglionic neurons	23276
the intermediolateral columns -LRB- Fig. 2B -RRB-	23313
the intermediolateral columns	23313
Fig. 2B	23344
all animals	23357
OECs	23370
clusters or furrowed alongside the sympathetic preganglionic neuron columns	23409
clusters	23409
furrowed alongside the sympathetic preganglionic neuron columns	23421
the sympathetic preganglionic neuron	23440
Anti-choline acetyltransferase staining -LRB- red -RRB-	23486
Anti-choline acetyltransferase staining	23486
red	23527
a group of sympathetic preganglionic neurons near a column of GFP-OECs -LRB- Fig. 2C -RRB-	23538
a group	23538
sympathetic preganglionic neurons near a column of GFP-OECs -LRB- Fig. 2C -RRB-	23549
sympathetic preganglionic neurons	23549
a column of GFP-OECs -LRB- Fig. 2C -RRB-	23588
a column	23588
GFP-OECs -LRB- Fig. 2C -RRB-	23600
GFP-OECs	23600
Fig. 2C	23610
Confocal imaging	23620
the presence of GFP-OECs in the close vicinity of sympathetic preganglionic neurons -LRB- Fig. 2D -RRB-	23645
the presence	23645
GFP-OECs in the close vicinity of sympathetic preganglionic neurons -LRB- Fig. 2D -RRB-	23661
GFP-OECs	23661
the close vicinity of sympathetic preganglionic neurons -LRB- Fig. 2D -RRB-	23673
the close vicinity	23673
sympathetic preganglionic neurons -LRB- Fig. 2D -RRB-	23695
sympathetic preganglionic neurons	23695
Fig. 2D	23730
3.3	23740
OEC transplantation	23745
morphology of sympathetic preganglionic neurons There were differences between animals transplanted with OEC or fibroblasts in the morphology of preganglionic sympathetic neurons	23773
morphology	23773
sympathetic preganglionic neurons	23787
There	23821
differences between animals transplanted with OEC or fibroblasts in the morphology of preganglionic sympathetic neurons	23832
differences	23832
animals transplanted with OEC or fibroblasts in the morphology of preganglionic sympathetic neurons	23852
animals	23852
OEC or fibroblasts	23878
the morphology of preganglionic sympathetic neurons	23900
the morphology	23900
preganglionic sympathetic neurons	23918
Morphometric features of NADPH-diaphorase-immunoreactive sympathetic preganglionic neurons in the intermediolateral columns rostral and caudal to the spinal cord transection site	23953
Morphometric features	23953
NADPH-diaphorase-immunoreactive sympathetic preganglionic neurons in the intermediolateral columns rostral and caudal to the spinal cord transection site	23978
NADPH-diaphorase-immunoreactive sympathetic preganglionic neurons	23978
the intermediolateral columns rostral and caudal to the spinal cord transection site	24047
the intermediolateral columns	24047
the spinal cord transection site	24099
9 weeks	24146
spinal cord injury	24160
completion of functional assessments	24185
completion	24185
functional assessments	24199
Soma size , overall dendrite length and number of primary dendrites	24223
Soma size	24223
overall dendrite length	24234
number of primary dendrites	24262
number	24262
primary dendrites	24272
the transplanted groups	24312
a 3 × 2 -LRB- group × position -RRB- linear mixed model analysis	24342
3 ×	24344
2	24348
group × position	24351
group	24351
× position	24357
The mean soma size	24398
significantly smaller caudal vs. rostral	24421
the injury -LRB- p = 0.03 -RRB-	24465
the injury	24465
p	24477
0.03	24481
A trend towards smaller soma size	24488
A trend	24488
smaller soma size	24504
the OEC-treated animals	24534
the fibroblast-treated animals -LRB- p = 0.07 -RRB-	24570
the fibroblast-treated animals	24570
p	24602
0.07	24606
Mean sympathetic preganglionic neuron dendritic length	24613
Mean sympathetic preganglionic neuron	24613
dendritic length	24651
the caudal vs. rostral position -LRB- p = 0.0001 -RRB-	24683
the caudal	24683
rostral position -LRB- p = 0.0001 -RRB-	24698
rostral position	24698
p	24716
0.0001	24720
The overall number of primary dendrites	24729
The overall number	24729
primary dendrites	24751
the caudal position -LRB- p = 0.02 -RRB-	24784
the caudal position	24784
p	24805
0.02	24809
the OECtreated animals -LRB- p = 0.005 -RRB-	24822
the OECtreated animals	24822
p	24846
0.005	24848
No statistically significant interactions between position and treatment	24856
No statistically significant interactions	24856
position and treatment	24906
3.4	24944
OEC transplantation	24949
synaptic density	24977
the somata of sympathetic preganglionic neurons	24997
the somata	24997
sympathetic preganglionic neurons	25011
Synaptic densities	25045
the overlay of the punctate synaptophysin immunoreactivitywith	25083
the overlay	25083
the punctate synaptophysin immunoreactivitywith	25098
the choline acetyltransferase immunoreactivity of the preganglionic sympathetic neurons -LRB- Fig. 3A , B -RRB-	25146
the choline acetyltransferase immunoreactivity	25146
the preganglionic sympathetic neurons -LRB- Fig. 3A , B -RRB-	25196
the preganglionic sympathetic neurons	25196
Fig. 3A , B	25235
Fig. 3A	25235
B	25244
the GFP-OECs transplanted group , caudal to the injury site	25251
the GFP-OECs	25251
group , caudal to the injury site	25277
group	25277
caudal to the injury site	25284
caudal	25284
the injury site	25294
numerous sympathetic preganglionic neurons with large numbers of synaptophysin-positive puncta	25311
numerous sympathetic preganglionic neurons	25311
large numbers of synaptophysin-positive puncta	25359
large numbers	25359
synaptophysin-positive puncta	25376
Fig. 3A	25421
fibroblasts-transplanted rats	25442
sympathetic preganglionic neurons	25473
less synaptophysin staining -LRB- Fig. 3B -RRB-	25514
less synaptophysin staining	25514
Fig. 3B	25543
The sympathetic preganglionic neuron synaptic density	25553
the sympathetic preganglionic neurons rostral vs. caudal to the injury site -LRB- p ≤ 0.003 -RRB-	25621
the sympathetic preganglionic neurons	25621
caudal to the injury site -LRB- p ≤ 0.003 -RRB-	25671
caudal to the injury site	25671
the injury	25681
p ≤ 0.003	25698
p	25698
≤ 0.003	25700
Comparison between OEC-transplanted animals and fibroblasttransplanted animals	25710
Comparison	25710
OEC-transplanted animals and fibroblasttransplanted animals	25729
OEC-transplanted animals	25729
fibroblasttransplanted animals	25758
an increased synaptic density in OECstransplanted animals caudal to the injury site -LRB- p = 0.05 -RRB- -LRB- Fig. 3C -RRB-	25798
an increased synaptic density	25798
OECstransplanted animals caudal to the injury site -LRB- p = 0.05 -RRB- -LRB- Fig. 3C -RRB-	25831
OECstransplanted animals	25831
the injury site -LRB- p = 0.05 -RRB- -LRB- Fig. 3C -RRB-	25866
the injury site -LRB- p = 0.05 -RRB-	25866
the injury site	25866
p	25883
0.05	25887
Fig. 3C	25894
No statistically significant interaction between position and treatment	25904
No statistically significant interaction	25904
position and treatment	25953
p = 0.36	25990
p	25990
= 0.36	25991
Discussion This study	26004
Discussion	26004
This study	26015
a cell	26039
type-specific therapeutic effect on autonomic dysreflexia of transplantation of OECs	26046
type-specific therapeutic effect	26046
autonomic dysreflexia of transplantation of OECs	26082
autonomic dysreflexia	26082
transplantation of OECs	26107
transplantation	26107
OECs	26126
fibroblasts	26143
This effect of OECs	26156
This effect	26156
OECs	26171
our previous observations	26185
a non-cell control group -LRB- Kalincik et al. , 2010a -RRB-	26216
a non-cell control group	26216
Kalincik	26242
et al. , 2010a	26251
et al.	26251
2010a	26259
this study	26281
survival of OECs	26303
survival	26303
OECs	26315
transplantation	26336
the spinal cord tissue adjacent to the lesion site -LRB- at least 9 weeks survival -RRB-	26357
the spinal cord tissue adjacent to the lesion site	26357
the spinal cord tissue	26357
the lesion site	26392
9 weeks	26418
survival	26426
the lesion itself -LRB- 3weeks ; Kalincik et al. , 2010a -RRB-	26453
the lesion itself	26453
the lesion	26453
3weeks ; Kalincik et al. , 2010a	26472
3weeks	26472
Kalincik et al. , 2010a	26480
Kalincik	26480
et al. , 2010a	26489
et al.	26489
2010a	26497
The histological analysis	26505
a mechanism involving reorganization of the synaptic inputs to sympathetic preganglionic neurons	26540
a mechanism	26540
reorganization of the synaptic inputs to sympathetic preganglionic neurons	26562
reorganization	26562
the synaptic inputs to sympathetic preganglionic neurons	26580
the synaptic inputs	26580
sympathetic preganglionic neurons	26603
their primary dendrites	26641
the site of spinal cord injury	26675
the site	26675
spinal cord injury	26687
4.1	26707
mean arterial pressure and heart rate After T4 spinal cord transection injury	26720
mean arterial pressure and heart rate	26720
mean arterial pressure	26720
heart rate	26747
T4 spinal cord transection injury	26764
T4	26764
spinal cord transection injury	26767
there	26798
a fall in resting mean arterial pressure accompanied by a rise in resting heart rate , with both cardiovascular parameters remaining stable at their new baseline values for 3 -- 8 weeks after injury -LRB- Kalincik et al. , 2010a ; Krassioukov et al. , 1995 ; Laird et al. , 2006 -RRB-	26807
a fall	26807
mean arterial pressure accompanied by a rise in resting heart rate , with both cardiovascular parameters remaining stable at their new baseline values for 3 -- 8 weeks after injury -LRB- Kalincik et al. , 2010a ; Krassioukov et al. , 1995 ; Laird et al. , 2006 -RRB-	26825
mean arterial pressure	26825
a rise	26863
heart rate	26881
both cardiovascular parameters remaining stable at their new baseline values for 3 -- 8 weeks after injury -LRB- Kalincik et al. , 2010a ; Krassioukov et al. , 1995 ; Laird et al. , 2006 -RRB-	26898
both cardiovascular parameters	26898
their new baseline values	26949
3	26979
8 weeks	26981
injury	26995
Kalincik et al. , 2010a ; Krassioukov et al. , 1995 ; Laird et al. , 2006	27003
Kalincik	27003
et al. , 2010a ; Krassioukov et al. , 1995 ; Laird et al. , 2006	27012
et al. , 2010a	27012
et al.	27012
2010a	27020
Krassioukov et al. , 1995	27027
Krassioukov	27027
et al. , 1995	27039
et al.	27039
1995	27047
Laird et al. , 2006	27053
Laird	27053
et al. , 2006	27059
et al.	27059
2006	27067
Transplantation of OECs	27074
Transplantation	27074
OECs	27093
these baseline	27113
measurements in this study -LRB- data not shown -RRB- or previously	27128
measurements in this study -LRB- data not shown -RRB-	27128
measurements	27128
this study -LRB- data not shown -RRB-	27144
this study	27144
data not shown	27156
data	27156
Kalincik et al. , 2010a	27187
Kalincik	27187
et al.	27196
2010a	27204
4.2	27212
Olfactory ensheathing cell and autonomic dysreflexia OEC transplantation into the lesion site -LRB- Kalincik et al. , 2010a -RRB- or the spinal cord parenchyma -LRB- present study -RRB-	27217
Olfactory ensheathing cell	27217
autonomic dysreflexia OEC transplantation into the lesion site -LRB- Kalincik et al. , 2010a -RRB- or the spinal cord parenchyma -LRB- present study -RRB-	27248
autonomic dysreflexia OEC transplantation	27248
the lesion site -LRB- Kalincik et al. , 2010a -RRB- or the spinal cord parenchyma -LRB- present study -RRB-	27295
the lesion site	27295
Kalincik	27312
et al. , 2010a	27321
et al.	27321
2010a	27329
the spinal cord parenchyma	27339
present study	27367
a faster recovery of the mean arterial pressure response	27391
a faster recovery	27391
the mean arterial pressure response	27412
colorectal distensions compared to the control groups	27451
colorectal distensions	27451
the control groups	27486
OEC transplantation into the spinal cord parenchyma	27506
OEC transplantation	27506
the spinal cord parenchyma	27531
a 26 % reduction of the period of increased arterial pressure quantified in the T50 mean arterial pressure response measured 6 -- 8 weeks after spinal cord injury , similar to the previously reported 22 % reduction measured 3 -- 8 weeks after spinal cord injury and OEC transplantation into the lesion site -LRB- Kalincik et al. , 2010a -RRB-	27570
a 26 % reduction	27570
the period of increased arterial pressure quantified in the T50 mean arterial pressure response measured 6 -- 8 weeks after spinal cord injury , similar to the previously reported 22 % reduction measured 3 -- 8 weeks after spinal cord injury and OEC transplantation into the lesion site	27589
the period	27589
increased arterial pressure quantified in the T50 mean arterial pressure response measured 6 -- 8 weeks after spinal cord injury , similar to the previously reported 22 % reduction measured 3 -- 8 weeks after spinal cord injury and OEC transplantation into the lesion site	27603
increased arterial pressure	27603
the T50	27645
arterial pressure response	27658
6	27694
8 weeks	27696
spinal cord injury , similar to the previously reported 22 % reduction measured 3	27710
spinal cord injury	27710
the previously reported 22 % reduction measured 3	27741
the previously reported 22 % reduction	27741
3	27788
8 weeks after spinal cord injury and OEC transplantation into the lesion site	27790
8 weeks	27790
spinal cord injury and OEC transplantation into the lesion site	27804
spinal cord injury and OEC transplantation	27804
the lesion site	27852
Kalincik	27869
et al. , 2010a	27878
et al.	27878
2010a	27886
analysis on weeks 6 to 8	27903
analysis	27903
weeks 6 to 8	27915
the faster recovery from hypertension	27955
the faster recovery	27955
hypertension	27980
OECs transplanted animals faded at 8 weeks	28005
OECs	28005
transplanted animals	28010
8 weeks	28040
The longer survival of OECs in the present study	28049
The longer survival	28049
OECs in the present study	28072
OECs	28072
the present study	28080
the reduction of autonomic dysreflexia	28114
the reduction	28114
autonomic dysreflexia	28131
the therapeutic effect of OECs	28171
the therapeutic effect	28171
OECs	28197
their continuing survival	28240
Further studies	28267
the mechanism underlying the transient effect in order to improve the therapeutic beneficial effect	28311
the mechanism	28311
the transient effect	28336
the therapeutic beneficial effect	28377
4.3	28412
Olfactory ensheathing cell and sympathetic preganglionic neuron morphology The number of primary dendrites caudal to the spinal cord injury	28417
Olfactory ensheathing cell	28417
sympathetic preganglionic neuron morphology The number of primary dendrites caudal to the spinal cord injury	28448
sympathetic preganglionic neuron morphology	28448
The number of primary dendrites	28492
The number	28492
primary dendrites	28506
the spinal cord injury	28534
OEC transplanted animals which demonstrates a cell specific action and confirms that OECs can change the sympathetic preganglionic neuronmorphology in vivo as previously shown by our group -LRB- Kalincik et al. , 2010b -RRB-	28586
OEC transplanted animals	28586
a cell specific action	28630
OECs	28671
the sympathetic preganglionic neuronmorphology	28687
our group -LRB- Kalincik et al. , 2010b -RRB-	28765
our group	28765
Kalincik	28776
et al. , 2010b	28785
et al.	28785
2010b	28793
This	28801
the primary dendrites	28820
the spinal cord injurymight	28852
a key role	28885
the reduction of autonomic dysreflexia seen in OECs	28899
the reduction	28899
autonomic dysreflexia seen in OECs	28916
autonomic dysreflexia	28916
OECs	28946
transplanted animals	28951
It	28973
we	29008
the same pattern	29020
the effect of treatment	29041
the effect	29041
treatment	29055
soma size -LRB- Kalincik et al. , 2010b -RRB-	29068
soma size	29068
Kalincik	29079
et al. , 2010b	29088
et al.	29088
2010b	29096
it	29113
a statistically significant level	29130
the other hand	29168
the relative increase in dendritic length rostral to the lesion -LRB- Kalincik et al. , 2010b -RRB-	29184
the relative increase	29184
dendritic length rostral to the lesion -LRB- Kalincik et al. , 2010b -RRB-	29209
dendritic length rostral	29209
the lesion -LRB- Kalincik et al. , 2010b -RRB-	29237
the lesion	29237
Kalincik	29249
et al. , 2010b	29258
et al.	29258
2010b	29266
the present study	29294
The reasons underlying those differences	29313
The reasons	29313
those differences	29336
a different transplant site environment plus a longer survival time of OECs	29393
a different transplant site environment	29393
a longer survival time of OECs	29438
a longer survival time	29438
OECs	29464
Another hypothetic reason	29470
fibroblasts	29516
Fibroblasts	29529
a control cell	29566
various candidate cells studied for transplant mediated repair	29592
various candidate cells	29592
transplant	29628
repair	29648
The use of this cell type for this purpose	29656
The use	29656
this cell type for this purpose	29667
this cell type	29667
this purpose	29686
the assumption	29711
they	29731
a neutral cell type with little or no repair promoting properties -LRB- Keyvan-Fouladi et al. , 2005 ; Pearse et al. , 2007 -RRB-	29740
a neutral cell type	29740
little or no repair promoting properties -LRB- Keyvan-Fouladi et al. , 2005 ; Pearse et al. , 2007 -RRB-	29765
little or no repair	29765
properties -LRB- Keyvan-Fouladi et al. , 2005 ; Pearse et al. , 2007 -RRB-	29795
properties	29795
Keyvan-Fouladi	29807
et al. , 2005 ; Pearse et al. , 2007	29822
et al.	29822
2005 ; Pearse et al.	29830
2005	29830
Pearse et al.	29836
Pearse	29836
et al.	29843
2007	29851
fibroblasts	29867
nerve growth factor -LRB- Olgart et al. , 2001 -RRB-	29900
nerve growth factor	29900
Olgart	29921
et al. , 2001	29928
et al.	29928
2001	29936
it	29946
fibroblast-like cells	29979
significant regeneration of axons after transplantation	30013
significant regeneration	30013
axons after transplantation	30041
axons	30041
transplantation	30053
dorsal column lesions -LRB- Toft et al. , 2013 -RRB- or improved locomotor scores -LRB- Suh et al. , 2011 -RRB-	30074
dorsal column lesions -LRB- Toft et al. , 2013 -RRB-	30074
dorsal column lesions	30074
Toft	30097
et al. , 2013	30102
et al.	30102
2013	30110
improved locomotor scores -LRB- Suh et al. , 2011 -RRB-	30119
improved locomotor scores	30119
Suh	30146
et al. , 2011	30150
et al.	30150
2011	30158
Fibroblasts	30165
astroglial scar formation and increase immune-cell infiltration and concomitant secondary tissue damage -LRB- Khankan et al. , 2016 -RRB-	30188
astroglial scar formation and increase immune-cell infiltration	30188
concomitant secondary tissue damage -LRB- Khankan et al. , 2016 -RRB-	30256
concomitant secondary tissue damage	30256
Khankan	30293
et al. , 2016	30301
et al.	30301
2016	30309
No studies	30316
the impacts of fibroblasts	30345
the impacts	30345
fibroblasts	30360
autonomic dysreflexia	30381
the morphology of sympathetic preganglionic neurons	30410
the morphology	30410
sympathetic preganglionic neurons	30428
we	30473
a potential effect of fibroblasts on sympathetic preganglionic neuronswhich could explain our differences compared to our previous study -LRB- Kalincik et al. , 2010a -RRB-	30492
a potential effect	30492
fibroblasts on sympathetic preganglionic neuronswhich	30514
fibroblasts	30514
sympathetic preganglionic neuronswhich	30529
our differences	30582
our previous study -LRB- Kalincik et al. , 2010a -RRB-	30610
our previous study	30610
Kalincik	30630
et al. , 2010a	30639
et al.	30639
2010a	30647
4.4	30655
Olfactory ensheathing cell and synaptic density	30660
Olfactory ensheathing cell	30660
synaptic density	30691
The anatomy of synaptic circuits controlling sympathetic preganglionic neuron activity is complex with excitatory or inhibitory synaptic connections arising from the brain stem and from spinal interneurons	30708
The anatomy	30708
synaptic circuits controlling sympathetic preganglionic neuron activity is complex with excitatory or inhibitory synaptic connections arising from the brain stem and from spinal interneurons	30723
synaptic circuits	30723
sympathetic preganglionic neuron activity is complex with excitatory or inhibitory synaptic connections arising from the brain stem and from spinal interneurons	30753
sympathetic preganglionic neuron activity	30753
excitatory or inhibitory synaptic connections arising from the brain stem and from spinal interneurons	30811
excitatory or inhibitory synaptic connections	30811
the brain stem	30870
spinal interneurons	30894
Llewellyn-Smith	30915
2009	30932
OEC transplantation	30939
the density of synaptic contacts	30969
the density	30969
synaptic contacts	30984
spinal cord injury	31012
fibroblast transplantation	31043
the improvement in autonomic dysreflexia	31077
the improvement	31077
autonomic dysreflexia	31096
OEC transplantation	31124
it	31144
this increase in synaptic density on caudal sympathetic ganglionic neurons	31164
this increase	31164
synaptic density on caudal sympathetic ganglionic neurons	31181
synaptic density	31181
caudal sympathetic ganglionic neurons	31201
OECinduced neuroplasticity	31248
our best knowledge	31279
it	31299
the first report	31305
OECs	31327
a modulatory effect on synaptic density sympathetic preganglionic neurons in vivo	31337
a modulatory effect	31337
synaptic density sympathetic preganglionic neurons in vivo	31360
synaptic density sympathetic preganglionic neurons	31360
vivo	31414
we	31423
transplanted OECs	31453
autonomic dysreflexia	31482
changes	31519
sympathetic preganglionic neurons morphology and synaptic density that indicate therapeutic neuroplasticity	31530
sympathetic preganglionic neurons morphology	31530
synaptic density that indicate therapeutic neuroplasticity	31579
synaptic density	31579
therapeutic neuroplasticity	31610
These benefits	31639
the OECs	31669
the time of the spinal cord injury	31699
the time	31699
the spinal cord injury	31711
the first human clinical trials of transplanted autologous OECs	31744
the first human clinical trials	31744
transplanted autologous OECs	31779
patients with chronicmid-thoracic spinal cord injuries -LRB- Feron et al. , 2005 ; Tabakow et al. , 2014 -RRB-	31830
patients	31830
chronicmid-thoracic spinal cord injuries -LRB- Feron et al. , 2005 ; Tabakow et al. , 2014 -RRB-	31844
chronicmid-thoracic spinal cord injuries	31844
Feron	31886
et al. , 2005 ; Tabakow et al. , 2014	31892
et al.	31892
2005 ; Tabakow et al.	31900
2005	31900
Tabakow et al.	31906
Tabakow	31906
et al.	31914
2014	31922
It	31929
patients with chronic high-thoracic injuries and autonomic dysreflexia	31971
patients	31971
chronic high-thoracic injuries and autonomic dysreflexia	31985
chronic high-thoracic injuries	31985
autonomic dysreflexia	32020
OEC transplantation	32060
chronic injuries	32084
the more likely clinical application	32105
